发明名称 Protein Kinase C Inhibitors
摘要 <p>The present invention discloses compounds that are highly isozyme selective protein kinase C beta-1 and beta-2 isozyme inhibitors. Accordingly, the present invention provides a method of selectively inhibiting protein kinase C isozymes beta-1, and beta-2. As isozyme selective inhibitors of beta-1 and beta-2, the compounds are therapeutically useful in treating conditions associated with diabetes mellitus and its complications, as well as other disease states associated with an elevation of the beta-1 and beta-2 isozyme.</p>
申请公布号 EP1449529(A1) 申请公布日期 2004.08.25
申请号 EP20040102054 申请日期 1994.12.14
申请人 ELI LILLY AND COMPANY 发明人 HEATH, WILLIAM FRANCIS HEATH JUNIOR;MCDONALD, JOHN HAMPTON III;PAAL, MICHAEL;RUHTER, GERD;THEO, SCHOTTEN;STENZEL, WOLFGANG
分类号 A61K31/40;C07D487/04;A61K31/4025;A61K31/404;A61K31/437;A61K31/44;A61K31/445;A61K31/454;A61K31/55;A61K31/70;A61K31/7056;A61P3/10;A61P7/02;A61P9/00;A61P9/10;A61P9/12;A61P17/00;A61P17/06;A61P25/00;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07D209/00;C07D221/00;C07D223/00;C07D401/14;C07D403/04;C07D403/14;C07D405/04;C07D405/14;C07D471/04;C07H15/26;(IPC1-7):A61K31/40 主分类号 A61K31/40
代理机构 代理人
主权项
地址